Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer

Journal of Clinical Pathology

Volumn 59, Issue 4, 2006, Pages 429-433

  Kanczuga Koda, L ^a   Sulkowski, S ^a   Lenczewski, A ^a   Koda, M ^a   Wincewicz, A ^a   Baltaziak, M ^a   Sulkowska, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 26; CONNEXIN 43;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE; CONNEXIN 43; CONNEXINS; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 33645695606     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.029272     Document Type: Article

References (40)

1. Aasen T, Hodgins MB, Edward M, et al. The relationship between connexins, gap junctions, tissue architecture and tumour invasion, as studied in a novel in vitro model of HPV-16-associated cervical cancer progression. Oncogene 2003;22:7969-80.
2. Lin JH, Takano T, Cotrina ML, et al. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci 2002;22:4302-11.
3. el-Sabban ME, Pauli BU. Cytoplasmic dye transfer between metastatic tumor cells and vascular endothelium J Cell Biol 1991;115:1375-82.
4. el-Sabban ME, Pauli BU. Adhesion-mediated gap junctional communication between lung-metastatatic cancer cells and endothelium. Invasion Metastasis 1994;14:164-76.
5. Ito A, Katoh F, Kataoka TR, et al. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest 2000;105:1189-97.
6. Willecke K, Eiberger J, Degen J, et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002;383:725-37.
7. Monaghan P, Clarke C, Perusinghe NP, et al. Gap junction distribution and connexin expression in human breast. Exp Cell Res 1996;223:29-38.
8. Trosko JE, Ruch RJ. Cell-cell communication in carcinogenesis. Front Biosci 1998;3:208-36.
9. Umhauer S, Ruch RJ, Fanning J. Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma. Am J Obstet Gynecol 2000;182:999-1000.
10. Ruch RJ, Porter S, Koffler LD, et al. Defective gap junctional intercellular communication in lung cancer: loss of an important mediator of tissue homeostasis and phenotypic regulation Exp Lung Res 2001;27:231-43.
11. Gee J, Tanaka M, Grossman HB. Connexin 26 is abnormally expressed in bladder cancer. J Urol 2003;169:1135-7.
12. Krutovskikh V, Mazzoleni G, Mironov N, et al. Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer 1994;56:87-94.
13. Defamie N, Mograbi B, Roger C, et al. Disruption of gap junctional intercellular communication by lindane is associated with aberrant localization of connexin43 and zonula occludens-1 in 42GPA9 Sertoli cells. Carcinogenesis 2001;22:1537-42.
14. Navolotski A, Rumjnzev A, Lu H, et al. Migration and gap junctional intercellular communication determine the metastatic phenotype of human tumor cell lines. Cancer Lett 1997;118:181-7.
15. Nicolson GL, Dulski KM, Trosko JE. Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells. Proc Natl Acad Sci USA 1988;85:473-6.
16. Kamibayashi Y, Oyamada Y, Mori M, et al. Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis 1995;16:1287-97.
17. Kanczuga-Koda L, Sulkowski S, Koda M, et al. Expression of connexins 26, 32 and 43 in the human colon-an immunohistochemical study. Folia Histochem Cytobiol 2004;42:203-7.
18. Brauner T, Schmid A, Hulser DF. Tumor cell invasion and gap junctional communication. I. Normal and malignant cells confronted in monolayer cultures. Invasion Metastasis 1990;10:18-30.
19. Carystinos GD, Bier A, Batist G. The role of connexin-mediated cell-cell communication in breast cancer metastasis. J Mammary Gland Biol Neoplasia 2001;6:431-40.
20. Krutovskikh VA, Troyanovsky SM, Piccoli C, et al. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene 2000;19:505-13.
21. Kanczuga-Koda L, Sulkowska M, Koda M, et al. Expression of connexin 43 in breast cancer in comparison with mammary dysplasia and the normal mammary gland. Folia Morphol 2003;62:439-42.
22. Kanczuga-Koda L, Sulkowski S, Tomaszewski J, et al. Connexin26 and 43 correlate with Bak, but not with bcl-2 protein in breast cancer. Oncol Rep 2005;14:325-9.
23. Kanczuga-Koda L, Sulkowski S, Koda M, et al. Alterations in connexin26 expression during colorectal carcinogenesis. Oncology 2005;68:217-22.
24. Chen SC, Pelletier DB, Ao P, et al. Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. Cell Growth Differ 1995;6:681-690.
25. Lecanda F, Towler DA, Ziambaras K, et al. Gap junctional communication modulates gene expression in osteoblastic cells. Mol Biol Cell 1998;9:2249-58.
26. Kanczuga-Koda L, Sulkowski S, Koda M, et al. Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer. World J Gastroenterol 2005;11:1544-8.
27. Lin JH, Takano T, Cotrina ML, et al. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci 2002;22:4302-11.
28. Mareel M, Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 2003;83:337-76.
29. Kapoor P, Sounders MM, Li Z, et al. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. Int J Cancer 2004;111:693-7.
30. Pollmann M, Shao Q, Laird DW, et al. Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res 2005;7:522-34.
31. Donahue HJ, Saunders MM, Li Z, et al. A potential role for gap junctions in breast cancer metastasis to bone. J Musculoskelet Neuronal Interact 2003;3:156-61.
32. Lewalle JM, Cataldo D, Bajou K, et al. Endothelial cell intracellular Ca2+ concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration. Clin Exp Metastasis 1998;16:21-9.
33. Hamada J, Takeichi N, Ren J, et al. Junctional communication of highly and weakly metastatic variant clones from a rat mammary carcinoma in primary and metastatic sites. Invasion Metastasis 1991;11:149-57.
34. Ren J, Hamada J, Takeichi N, et al. Ultrastructural differences in junctional intercellular communication between highly and weakly metastatic clones derived from rat mammary carcinoma. Cancer Res 1990;50:358-62.
35. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998;153:333-9.
36. Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001;3:289-93.
37. Bremnes RM, Veve R, Hirsch FR, et al. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis, lung Cancer 2002;36:115-24.
38. Byrne RR, Shariat SF, Brown R, et al. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term follow up. J Urol 2001;165:1473-9.
39. Mayer B, Johnson JP, Leitl F, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular differentiation and glandular disintegration. Cancer Res 1993;53:1690-5.
40. Bukholm IK, Nesland JM, Borresen-Dale AL. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients. J Pathol 2000;190:15-19.